Delivery Order SPE2DB22D2206-SPE2DB25FJN72
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,542.48 to AmerisourceBergen Drug Corp for the supply of Piperacillin-Tazobactam 3.375 GM VLS, an antibiotic combination medication. Awarded on April 24, 2025, with an ultimate completion date of April 25, 2025, this firm fixed-price delivery order represents a routine pharmaceutical procurement supporting federal medical supply needs. The contract carries no set-aside designation, indicating it was competitively awarded through...
- The Defense Logistics Agency awarded a delivery order valued at $1,169.15 to AmerisourceBergen Drug Corp for the supply of Piperacillin-Tazobactam 4.5 GM vials. The award, issued on January 23, 2026, is a firm fixed-price delivery order with an ultimate completion date of January 26, 2026. The contract was competitively awarded with no set-aside designation, and the place of performance is located in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., one of...
- The Defense Logistics Agency awarded a $4,730.96 delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Piperacillin-Tazobactam 4.5 GM vials, with performance completion scheduled for July 25, 2025. This contract was competitively awarded without set-aside restrictions and operates under firm fixed-price terms. The pharmaceutical antibiotic product will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania, where the company maintains its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 10, 2025, for the supply of Piperacillin-Tazobactam 4.5 GM vials, a broad-spectrum antibiotic combination used in military and federal healthcare settings. This competitively awarded, non-set-aside contract has a ceiling value of $7,716.51 with a firm fixed-price structure and an ultimate completion date of November 12, 2025. The pharmaceutical products will be delivered to AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Piperacillin-Tazobactam 4.5 gram vials, with a contract ceiling value of $1,821.17. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded procurement. The product will be performed from AmerisourceBergen's location in Conshohocken, Pennsylvania, with an ultimate completion date of September 5, 2025. This delivery order is issued under...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,321.94 for piperacillin-tazobactam 4.5 GM vials by the Defense Logistics Agency's Medical Supply Chain on August 7, 2025. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of August 8, 2025, and performance occurring at the vendor's Conshohocken facility. The delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of piperacillin-tazobactam 4.5 GM add vials with a ceiling value of $2,562.17. This competitive, non-set-aside contract employs firm fixed price pricing and is scheduled for completion by August 1, 2025. The pharmaceutical products will be delivered to the company's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary...
- The Defense Logistics Agency awarded a delivery order valued at $3,097.32 to AmerisourceBergen Drug Corp for the supply of Piperacillin-Tazobactam 3.375G DPLXS, a combination antibiotic commonly used in hospital and military healthcare settings. This non-set-aside, competitively awarded contract employs firm fixed-price pricing and was issued on January 7, 2026, with an ultimate completion date of January 8, 2026. The product will be delivered to the awardee's facility in Conshohocken,...
- The Defense Logistics Agency awarded a $1,974.72 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Piperacillin-Tazobactam 4.5 GM vials, with an ultimate completion date of December 23, 2025. This competitive award carries no set-aside designation and represents a child contract under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical. The product will be delivered from the contractor's facility in Conshohocken,...
- The Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Piperacillin-Tazobactam 3.375 GM VLS, an antibiotic combination therapy. This firm fixed-price delivery order, valued at $3,922.69, represents a non-competitive award under an existing indefinite delivery contract. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 11, 2025....
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FJN72Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,173.78 to AmerisourceBergen Drug Corp for the supply of Piperacillin-Tazobactam 3.375 GM VLS, an antibiotic combination therapy commonly used in clinical settings. This competitively awarded, firm fixed-price delivery order was issued on August 21, 2025, with an ultimate completion date of August 22, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, indicating that it was awarded through open competition. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.99 billion global pharmaceutical support vehicle extending through December 2026. As a leading pharmaceutical distributor and critical federal vendor, AmerisourceBergen Drug Corp supplies a comprehensive range of medications and medical supplies to support military and veteran healthcare systems. The company's extensive portfolio of federal contract awards with DLA demonstrates its capability to fulfill diverse pharmaceutical procurement requirements across multiple therapeutic domains in support of the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 8/21/25 |